Autoimmune Diseases  >>  ASK8007  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ASK8007 / Astellas
NCT00411424: Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Completed
1/2
54
Europe
ASK8007, Placebo
Astellas Pharma Inc
Rheumatoid Arthritis
06/09
06/09

Download Options